Correlation Between Lantern Pharma and VTv Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and vTv Therapeutics, you can compare the effects of market volatilities on Lantern Pharma and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and VTv Therapeutics.
Diversification Opportunities for Lantern Pharma and VTv Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lantern and VTv is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and VTv Therapeutics go up and down completely randomly.
Pair Corralation between Lantern Pharma and VTv Therapeutics
Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the VTv Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lantern Pharma is 1.38 times less risky than VTv Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The vTv Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 1,476 in vTv Therapeutics on November 29, 2024 and sell it today you would earn a total of 388.00 from holding vTv Therapeutics or generate 26.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lantern Pharma vs. vTv Therapeutics
Performance |
| Timeline |
| Lantern Pharma |
| vTv Therapeutics |
Lantern Pharma and VTv Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lantern Pharma and VTv Therapeutics
The main advantage of trading using opposite Lantern Pharma and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.| Lantern Pharma vs. Beam Therapeutics | Lantern Pharma vs. Editas Medicine | Lantern Pharma vs. Caribou Biosciences | Lantern Pharma vs. Verve Therapeutics |
| VTv Therapeutics vs. Zura Bio Limited | VTv Therapeutics vs. Phio Pharmaceuticals Corp | VTv Therapeutics vs. Immix Biopharma | VTv Therapeutics vs. NovaBay Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |